Evaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea

BACKGROUND: Previous studies have indicated that ramosetron, a 5-hydroxytryptamine-3 receptor antagonist, achieves global improvement in irritable bowel syndrome (IBS) symptoms in male patients with IBS with diarrhea (IBS-D). However, in addition to global assessment it was deemed important to asses...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biopsychosoc Med
Main Authors: Ida, Motoko, Nishida, Akito, Akiho, Hiraku, Nakashima, Yoshihiro, Matsueda, Kei, Fukudo, Shin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5346243/
https://ncbi.nlm.nih.gov/pubmed/28293280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13030-017-0092-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados